Mark Tometsko
Impact in
- Oncology top 0.5%
- Bone health and treatments
- Cytokine Signaling Pathways and Interactions
- Cancer Research top 1%
- NF-κB Signaling Pathways
Papers in
- Oncology 13
- Bone health and treatments 7
- HER2/EGFR in Cancer Research 3
- Chemokine receptors and signaling 2
-
- Bone Metabolism and Diseases 11
- Co-authors
- William C. Dougall (10 shared papers)David Cosman (5 shared papers)Dirk Anderson (4 shared papers)Laurent Galibert (2 shared papers)Mark Teepe (1 shared paper)Robert DuBose (1 shared paper)Eugene Maraskovsky (1 shared paper)Eileen R. Roux (1 shared paper)
- Journals
- Journal of Biological Chemistry (4 papers)Cancer Research (4 papers)Blood (2 papers)Molecular Pharmaceutics (1 paper)Nature (1 paper)
- Partner nations
- United StatesSpainCanada
In The Last Decade
Mark Tometsko
18 papers receiving 4.2k citations
Mark Tometsko's Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 2.3k
- Cancer Research 1.1k
- Orthopedics and Sports Medicine 481
- Immunology 1.0k
- Molecular Biology 2.9k
Countries citing papers authored by Mark Tometsko
This map shows the geographic impact of Mark Tometsko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Tometsko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Tometsko more than expected).
Fields of papers citing papers by Mark Tometsko
This network shows the impact of papers produced by Mark Tometsko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Tometsko. The network helps show where Mark Tometsko may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Tometsko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function Hit paper breakdown → | 1997 | 1830 |
| 2 | RANK is essential for osteoclast and lymph node development Hit paper breakdown → | 1999 | 1158 |
| 3 | 1995 | 309 | |
| 4 | 1998 | 274 | |
| 5 | 2002 | 201 | |
| 6 | 2012 | 154 | |
| 7 | 2015 | 93 | |
| 8 | 2004 | 76 | |
| 9 | 2013 | 50 | |
| 10 | 2015 | 41 | |
| 11 | 2014 | 34 | |
| 12 | 2016 | 33 | |
| 13 | 2015 | 20 | |
| 14 | 2011 | 4 | |
| 15 | 2018 | 3 | |
| 16 | 2006 | 3 | |
| 17 | 2018 | 2 | |
| 18 | 2009 | 2 |
About Mark Tometsko
Mark Tometsko is a scholar working on Oncology, Molecular Biology, Cancer Research, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 4.3k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (11 papers), Bone health and treatments (7 papers), NF-κB Signaling Pathways (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Immunotherapy and Immune Responses (2 papers), Chemokine receptors and signaling (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Oncology (2.3k citations), Cancer Research (1.1k citations), Orthopedics and Sports Medicine (481 citations), Immunology (1.0k citations) and Molecular Biology (2.9k citations). Mark Tometsko has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include William C. Dougall, David Cosman, Dirk Anderson, Laurent Galibert, Mark Teepe, Robert DuBose, Eugene Maraskovsky, Eileen R. Roux, Allison Armstrong and Moira Glaccum. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, Blood, Molecular Pharmaceutics and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.